Sep 22, 2025 | Cost Savings, Drug costs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Transparency
Across the country, more employers are moving away from traditional pharmacy benefit managers in favor of transparent solutions. MedBen Rx has been ahead of this trend for years, offering clients clarity and lower costs that others are only now beginning to seek. A...
Aug 26, 2025 | Client Report, Cost management, Cost projections, Cost Savings, Direct-to-Employer Contracting, Drug costs, Health care costs, High-value formulary, Rx Costs, Savings, Wellness
A new national survey on employer health care strategies finds that employees are likely to see higher premiums and out-of-pocket costs in the years ahead, as overall health care expenses continue to rise. But for self-funded employers, asking employees to shoulder...
Aug 11, 2025 | Benefits preservation, Cost Savings, Drug costs, MedBen Rx, Rx Costs, Savings, Specialty Drugs
Specialty medications continue to drive a disproportionate share of prescription drug costs – often accounting for 60% or more of a pharmacy plan’s total spend. MedBen Rx’s Benefit Preservation helps plans manage these expenses without compromising care by...
Jul 29, 2025 | biologics, Biosimilars, Cost Savings, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings
The advantages of biosimilars – clinically equivalent versions of high-price biologic drugs – have been known for years. But despite their growing availability, adoption remains slow… in no small part because major PBMs are stifling uptake....
Jun 27, 2025 | Cost management, Cost Savings, Discounts, Forensic claims review, Health care costs, Savings
The 2025 MedBen Client Report highlights how our proven self-funding solutions have consistently helped employers control health care costs. One of the most impactful tools – forensic claims review – was introduced in 2007 and continues to deliver measurable value,...
Apr 21, 2025 | Biosimilars, Cost Savings, Drug costs, Rx Costs, Savings, Stelara
Earlier this month, MedBen Rx clients and their brokers were emailed about an opportunity to receive preferred pricing for the biosimilar for the anti-inflammatory medication Stelara. Depending on the dosage, this biosimilar can reduce the cost of the medication by...
